A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
7/17/2026
BreakingMyopiaRegulation
US FDA Advisory Panel Will Review Sydnexis’ NDA for SYD-101 in Myopia
Sydnexis announced July 13 that the US FDA would convene an advisory committee meeting to discuss SYD-101, the company’s low-dose atropine candidate for pediatric progressive myopia. The date for t...
7/17/2026
AllergyBreakingCataractPharmaRegulationRetina
US FDA Recalls 2.5 Million Bottles of Prednisolone Acetate Eye Drops
The US FDA has issued a Class II recall of more than 2.5 million bottles of prednisolone acetate 1% eye drops manufactured by Lupin Limited, citing the possibility of foreign particulate contaminat...
7/17/2026
BreakingClinical TrialGlaucomaRetina
Bausch + Lomb Drops Glaucoma Neuroprotection Program after Phase II Failure
Bausch + Lomb announced July 10 that it would discontinue development of a neuroprotective eye drop candidate for glaucoma, citing Phase II results in which BL1107, a prodrug of brimonidine tartrat...
7/17/2026
BreakingCataractIOLIndustrySurgical
RxSight Appoints Aziz Mottiwala as President, CEO
RxSight reported July 15 that it had appointedAziz Mottiwala as president and chief executive officer, effective July 20. Mottiwala succeeds Ron Kurtz, MD, who will continue to serve as chief medic...
7/17/2026
BreakingCataractIOLPremiumRevenueSurgical
J&J Vision Generates Q2-2026 Surgical Revenue of $426 Million
J&J Vision’s Q2-2026 global surgical revenue totaled $426 million, a 5.6 percent increase over $403 million in Q2-2025, parent Johnson & Johnson, of New Brunswick, New Jersey, reported July 15. Q2-...
7/17/2026
BreakingDealsDry EyeRetinaSurgical
Tarsus Acquires iRenix, Developer of Pre-procedure Ocular Antiseptic Candidate
Tarsus Pharmaceuticals announced July 8 that it had acquired iRenix Medical, of Palo Alto, California, developer of IRX-101, an investigational ocular antiseptic. Tarsus said it would pay approxima...
7/17/2026
BreakingPresbyopiaRegulation
Tenpoint Submits UK Marketing Application for Yuvezzi Presbyopia Drops
Tenpoint Therapeutics reported July 13 that it had submitted a marketing authorization application to the UK’s Medicines and Healthcare Products Regulatory Agency for Yuvezzi (carbachol and brimoni...
7/17/2026
BreakingChinaDry EyeRegulation
Hengrui’s Cyclosporine Eye Drop Formulation for Dry Eye Gains Approval in China
China’s Hengrui Pharmaceuticals and Germany’s Novaliq announced June 30 that China’s National Medical Products Administration had approved Heng Yi (0.1% cyclosporine ophthalmic solution) for dry ey...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.